FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * Alziari Lucien 2. Issuer Name and Ticker or Trading Symbol PRUDENTIAL FINANCIAL INC [ PRU ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
Executive Vice President
(Last)         (First)         (Middle)
751 BROAD STREET, 4TH FLOOR, ATTN: CORPORATE COMPLIANCE
3. Date of Earliest Transaction (MM/DD/YYYY)
2/9/2021
(Street)
NEWARK, NJ 07102
(City)       (State)       (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock  2/9/2021    M    10478 (1)(2) A $0  11681  D   
Common Stock  2/9/2021    F    3800 (3) D $81.43  7881  D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
2021 Restricted Stock Units   (4) 2/9/2021    A     6908       (5)  (5) Common Stock  6908  $0  6908  D   
2021 Performance Shares   (6) 2/9/2021    A     20724       (7)  (7) Common Stock  20724  $0  20724  D   
2018 Performance Shares  $0 (1) 2/9/2021    M        4923    (1)  (1) Common Stock  4923  $0  0  D   

Explanation of Responses:
(1)  The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2018 through 2020 performance period, as adjusted based on the results of an inclusion and diversity modifier.
(2)  Includes cash settled performance units which were converted from cash to equity settlement based on a decision by the Compensation Committee.
(3)  Represents shares withheld for the payment of taxes.
(4)  The Restricted Stock Units convert to common stock on a 1 to 1 basis.
(5)  The Restricted Stock Units will vest 1/3 per year beginning on February 28, 2022.
(6)  The performance shares convert to common stock on a 1 to 1 basis.
(7)  Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2024 based on the Company's ROE performance relative to certain life insurance peer companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2021 through 2023 performance period, as adjusted based on the results of an inclusion and diversity modifier.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Alziari Lucien
751 BROAD STREET, 4TH FLOOR
ATTN: CORPORATE COMPLIANCE
NEWARK, NJ 07102


Executive Vice President

Signatures
/s/ Richard J. Baker, attorney-in-fact 2/11/2021
**Signature of Reporting Person Date